15:0 Lyso PC

15:0 Lyso PC is a lysophosphatidylcholine (Lyso PC), a product of phospholipase A2 (PLA2) hydrolysis of phosphatidylcholine (PC) and is involved in cell membrane remodeling and inflammatory signaling. 15:0 Lyso PC demonstrates significant lipid metabolism disturbances in the serum with ischemic heart disease (IHD) and ischemic cardiomyopathy (ICM) . 15:0 Lyso PC can be used as a lipid biomarker for cardiovascular disease[1][2].

Product Specifications

CAS Number

[108273-89-8]

UNSPSC

12352200

Hazard Statement

H302, H315, H319, H335

Target

Endogenous Metabolite

Type

Biochemical Assay Reagents

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/15-0-lyso-pc.html

Purity

99.6

Smiles

CCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)O

Molecular Formula

C23H48NO7P

Molecular Weight

481.60

Precautions

H302, H315, H319, H335

References & Citations

[1]Mecatti GC, et al. Lipidomic Profiling of Plasma and Erythrocytes From Septic Patients Reveals Potential Biomarker Candidates. Biomark Insights. 2018 Mar 26;13:1177271918765137. |[2]Yang L, et al. Serum lipids profiling perturbances in patients with ischemic heart disease and ischemic cardiomyopathy. Lipids Health Dis. 2020 May 9;19 (1) :89.